An independent research revealed that METTL3 is elevated in AML and binds to the SP1 promoter region with the assistance of transcription factor CEBPZ, facilitating SP1 translation via relieving ribosome stalling (Barbieri et al., 2017). The gene discussed is METTL3; the disease is acute myeloid leukemia.